Giovanna Sophia Manzano (Brunetto), M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autoimmune Diseases of the Nervous System | 2 | 2024 | 75 | 1.690 |
Why?
|
Encephalitis | 2 | 2024 | 437 | 1.390 |
Why?
|
Multiple Sclerosis | 5 | 2024 | 3204 | 1.210 |
Why?
|
Hashimoto Disease | 2 | 2024 | 105 | 1.030 |
Why?
|
Limbic Encephalitis | 1 | 2023 | 36 | 0.890 |
Why?
|
Autoantibodies | 4 | 2024 | 2119 | 0.860 |
Why?
|
Familial Mediterranean Fever | 1 | 2023 | 65 | 0.840 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2024 | 550 | 0.810 |
Why?
|
Neuromyelitis Optica | 2 | 2022 | 259 | 0.760 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2021 | 68 | 0.740 |
Why?
|
Optic Neuritis | 2 | 2022 | 174 | 0.730 |
Why?
|
Demyelinating Diseases | 1 | 2023 | 351 | 0.720 |
Why?
|
Seizures, Febrile | 1 | 2021 | 108 | 0.720 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2021 | 65 | 0.710 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2018 | 42 | 0.620 |
Why?
|
Clozapine | 1 | 2021 | 506 | 0.600 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2021 | 640 | 0.570 |
Why?
|
Neurotoxicity Syndromes | 1 | 2021 | 299 | 0.570 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2022 | 556 | 0.550 |
Why?
|
Interferon Type I | 1 | 2020 | 559 | 0.550 |
Why?
|
Muscular Diseases | 1 | 2020 | 551 | 0.530 |
Why?
|
Methotrexate | 1 | 2021 | 1718 | 0.470 |
Why?
|
Antipsychotic Agents | 1 | 2021 | 3061 | 0.300 |
Why?
|
Phenotype | 1 | 2024 | 16548 | 0.270 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3610 | 0.250 |
Why?
|
HTLV-I Infections | 2 | 2015 | 103 | 0.240 |
Why?
|
Human T-lymphotropic virus 1 | 2 | 2015 | 142 | 0.240 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2024 | 38 | 0.230 |
Why?
|
Aquaporin 4 | 2 | 2022 | 159 | 0.230 |
Why?
|
Roseolovirus Infections | 1 | 2014 | 50 | 0.220 |
Why?
|
Herpesvirus 6, Human | 1 | 2014 | 97 | 0.220 |
Why?
|
Schizophrenia | 1 | 2021 | 6915 | 0.210 |
Why?
|
Tremor | 1 | 2023 | 187 | 0.210 |
Why?
|
Antipyretics | 1 | 2021 | 23 | 0.200 |
Why?
|
Leukoencephalitis, Acute Hemorrhagic | 1 | 2021 | 19 | 0.200 |
Why?
|
Colchicine | 1 | 2023 | 261 | 0.190 |
Why?
|
Dysarthria | 1 | 2021 | 58 | 0.190 |
Why?
|
Plasmapheresis | 1 | 2021 | 206 | 0.180 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 6065 | 0.180 |
Why?
|
Diplopia | 1 | 2021 | 215 | 0.170 |
Why?
|
Methylprednisolone | 1 | 2020 | 384 | 0.160 |
Why?
|
Virus Activation | 1 | 2021 | 319 | 0.160 |
Why?
|
Confusion | 1 | 2021 | 279 | 0.160 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 283 | 0.160 |
Why?
|
Muscle Weakness | 1 | 2021 | 413 | 0.150 |
Why?
|
Alanine | 1 | 2020 | 606 | 0.150 |
Why?
|
Acetaminophen | 1 | 2021 | 553 | 0.150 |
Why?
|
Steroids | 1 | 2022 | 928 | 0.140 |
Why?
|
Hematuria | 1 | 2018 | 233 | 0.140 |
Why?
|
Optic Nerve Diseases | 1 | 2020 | 342 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2021 | 664 | 0.140 |
Why?
|
Tears | 1 | 2018 | 251 | 0.140 |
Why?
|
Astrocytes | 1 | 2024 | 1337 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12968 | 0.130 |
Why?
|
Prednisone | 1 | 2020 | 1566 | 0.130 |
Why?
|
Humans | 19 | 2024 | 760613 | 0.130 |
Why?
|
Craniopharyngioma | 1 | 2018 | 277 | 0.130 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 753 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2020 | 520 | 0.120 |
Why?
|
Exanthema | 1 | 2018 | 504 | 0.110 |
Why?
|
Adult | 7 | 2024 | 220007 | 0.100 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4542 | 0.100 |
Why?
|
Recurrence | 2 | 2021 | 8483 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1588 | 0.100 |
Why?
|
Middle Aged | 7 | 2024 | 220359 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2145 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36286 | 0.100 |
Why?
|
Treatment Outcome | 3 | 2022 | 64981 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 1131 | 0.090 |
Why?
|
Retrospective Studies | 4 | 2024 | 80345 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3142 | 0.090 |
Why?
|
DNA, Viral | 2 | 2015 | 2194 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1313 | 0.080 |
Why?
|
Viral Load | 2 | 2015 | 3322 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3359 | 0.080 |
Why?
|
Stem Cells | 1 | 2022 | 3524 | 0.080 |
Why?
|
Male | 8 | 2024 | 359718 | 0.080 |
Why?
|
Female | 8 | 2024 | 391246 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2021 | 3736 | 0.070 |
Why?
|
Monocytes | 1 | 2015 | 2575 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4924 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18413 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15840 | 0.050 |
Why?
|
Serum | 1 | 2014 | 211 | 0.050 |
Why?
|
Blood Donors | 1 | 2014 | 343 | 0.050 |
Why?
|
Young Adult | 2 | 2024 | 58748 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40139 | 0.040 |
Why?
|
Saliva | 1 | 2014 | 820 | 0.040 |
Why?
|
Adolescent | 2 | 2024 | 87809 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 42056 | 0.040 |
Why?
|
Optic Nerve | 1 | 2020 | 567 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1827 | 0.040 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 521 | 0.030 |
Why?
|
Infant | 1 | 2018 | 36053 | 0.030 |
Why?
|
Child | 1 | 2024 | 79799 | 0.030 |
Why?
|
Receptors, CCR | 1 | 2015 | 37 | 0.030 |
Why?
|
Receptors, CXCR | 1 | 2015 | 52 | 0.030 |
Why?
|
Brain | 1 | 2021 | 26951 | 0.030 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 2014 | 32 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 74333 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1548 | 0.030 |
Why?
|
Aged | 3 | 2022 | 169143 | 0.030 |
Why?
|
Phagocytosis | 1 | 2015 | 1535 | 0.020 |
Why?
|
Mutation | 1 | 2014 | 29957 | 0.020 |
Why?
|
Cell Movement | 1 | 2015 | 5206 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2015 | 4353 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4550 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15286 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9278 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13308 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29661 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24102 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20080 | 0.010 |
Why?
|
Animals | 1 | 2020 | 167960 | 0.000 |
Why?
|